ELSS Tax Saving Funds: PGIM India ELSS Tax Saver mutual fund review: Good long-term performer


ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS

DATE OF LAUNCH

12 NOVEMBER 2015

CATEGORY

EQUITY

TYPE

ELSS

AUM*

Rs.388 Crore

BENCHMARK

NIFTY 500 TOTAL

RETURN INDEX

image-2

image-3


WHAT IT COSTS


NAV**

GROWTH OPTION

Rs 22.2

IDCW

Rs 15.18

MINIMUM INVESTMENT

Rs 500

MINIMUM SIP AMOUNT

Rs 500

EXPENSE RATIO*** (%)

2.53

EXIT LOAD: 0

**AS ON 7 JUNE 2022
*AS ON 30 APRIL 2022
***AS ON 30 APRIL 2022

image-4

image-5

FUND MANAGER

SRINIVAS RAO RAVURI

TENURE: 2 YEARS, 8 MONTHS

Recent portfolio changes

New Entrants: Bayer CropScience,

Co. .

Complete Exits: Mahindra & Mahindra, .

Increasing allocation: Aurobindo Pharma, , , , Dr. Reddy’s Laboratories, , , , The .

image-6

Should you buy?

Earlier known as PGIM India Long Term Equity, this fund takes a large-cap tilt like many of its peers. The rest is spread across mid- and small-caps. It runs a compact portfolio of less than 40 stocks, taking large positions in its top few bets. The fund prefers quality businesses with high ROCE and ROE, operating as a leader or competitive challenger in its space with clear visibility of earnings for the next 3-5 years. The fund has built a decent track record in a short span of time, with an ability to cushion against the market downside that is better than many of its peers. The presence of a skilled fund manager at its helm provides added comfort.

(Source: Value Research)



Source link